Headlines

Pacific Biosciences Of California Stock Plummets 18% In 5 Sessions

(VIANEWS) – Pacific Biosciences of California (PACB) shares experienced an extraordinary 18% drop over five sessions, from EUR11.01 to EUR9.02 at 13:39 EST on Thursday afternoon – following on a previous upward trend. Meanwhile, NASDAQ dropped 1.12% after two consecutive losses for both companies; Pacific Biosciences’ closing price on Thursday stood at EUR9.43 which represented…

Read More

Ebix Stock Plummets 14% As Investors Reject Impressive Earnings

(VIANEWS) – Ebix Shares Tumble 14.69% Amid Broader Market Decline Ebix Inc. (NASDAQ: EBIX) saw shares significantly drop 14.69% by 13:24 EST Tuesday afternoon to EUR11.18 following last session’s downward trend. Furthermore, market sentiment showed bearish signs with the NASDAQ index losing 0.6% of value and closing at EUR13,628.65. Ebix shares have fallen 60.15% since…

Read More

Aurora Cannabis Stock Plummets 12%: Investors Wary Amid Bearish Momentum

(VIANEWS) – Aurora Cannabis (NYSE: ACB) shares dropped 12.39% at 14:02 EST Monday after four consecutive sessions of gains, despite the overall market rising 0.06% and reaching EUR15,983.72. This decline came despite signs that overall sentiment had turned bullish despite rising 0.06 points to EUR15,983.72. About Aurora Cannabis Aurora Cannabis Inc. is a premier producer…

Read More

FibroGen Stock Plummets 30% In 21 Sessions: Is It Time To Sell?

(VIANEWS) – FibroGen (NASDAQ: FGEN) shares have seen an extraordinary decline of 30.15% over the last 21 sessions, falling from EUR1.36 to EUR0.95, continuing their downward momentum from prior sessions. Even as NASDAQ rose 0.83% to EUR13,928.34 during this time, FibroGen’s performance remains weak with their last closing price being EUR0.93, representing an approximately 96%…

Read More

Less Than One Hour Before The Market Open, Alnylam Pharmaceuticals Is Down By 5%

(VIANEWS) – The NASDAQ opens in less than one hour and Alnylam Pharmaceuticals‘s pre-market value is already 5.58% down. Alnylam Pharmaceuticals’s last close was $211.65, 12.89% below its 52-week high of $242.97. The last session, NASDAQ ended with Alnylam Pharmaceuticals (ALNY) dropping 0% to $211.65. NASDAQ rose 0.29% to $13,813.58, following the last session’s upward…

Read More